Fresenius Medical Care Past Earnings Performance
Past criteria checks 4/6
Fresenius Medical Care's earnings have been declining at an average annual rate of -20.9%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 2.7% per year. Fresenius Medical Care's return on equity is 5.9%, and it has net margins of 3.4%.
Key information
-20.9%
Earnings growth rate
-20.4%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 2.7% |
| Return on equity | 5.9% |
| Net Margin | 3.4% |
| Next Earnings Update | 25 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fresenius Medical Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 19,239 | 659 | 3,148 | 199 |
| 30 Jun 24 | 19,415 | 530 | 3,186 | 212 |
| 31 Mar 24 | 19,474 | 484 | 3,190 | 224 |
| 31 Dec 23 | 19,454 | 499 | 3,196 | 232 |
| 30 Sep 23 | 19,463 | 450 | 3,156 | 228 |
| 30 Jun 23 | 19,622 | 596 | 3,180 | 236 |
| 31 Mar 23 | 19,554 | 602 | 3,163 | 235 |
| 31 Dec 22 | 19,398 | 673 | 3,170 | 229 |
| 30 Sep 22 | 19,048 | 763 | 3,104 | 234 |
| 30 Jun 22 | 18,393 | 806 | 3,018 | 225 |
| 31 Mar 22 | 17,957 | 878 | 3,091 | 222 |
| 31 Dec 21 | 17,619 | 969 | 2,773 | 221 |
| 30 Sep 21 | 17,372 | 918 | 3,011 | 205 |
| 30 Jun 21 | 17,344 | 998 | 2,986 | 198 |
| 31 Mar 21 | 17,581 | 1,131 | 2,868 | 197 |
| 31 Dec 20 | 17,859 | 1,164 | 2,966 | 194 |
| 30 Sep 20 | 18,039 | 1,330 | 2,991 | 190 |
| 30 Jun 20 | 18,044 | 1,309 | 3,016 | 187 |
| 31 Mar 20 | 17,832 | 1,212 | 3,099 | 185 |
| 31 Dec 19 | 17,477 | 1,200 | 2,944 | 168 |
| 30 Sep 19 | 17,196 | 1,282 | 2,967 | 138 |
| 30 Jun 19 | 16,835 | 1,234 | 2,978 | 122 |
| 31 Mar 19 | 16,704 | 1,974 | 2,898 | 111 |
| 31 Dec 18 | 16,547 | 1,982 | 2,857 | 114 |
| 30 Sep 18 | 16,676 | 1,951 | 3,126 | 131 |
| 30 Jun 18 | 16,954 | 1,975 | 3,185 | 133 |
| 31 Mar 18 | 17,211 | 1,250 | 3,374 | 130 |
| 31 Dec 17 | 17,784 | 1,280 | 3,640 | 111 |
| 30 Sep 17 | 17,771 | 1,249 | 3,417 | 134 |
| 30 Jun 17 | 17,647 | 1,244 | 3,407 | 145 |
| 31 Mar 17 | 17,201 | 1,239 | 3,262 | 144 |
| 31 Dec 16 | 16,570 | 1,144 | 3,133 | 147 |
| 30 Sep 16 | 16,101 | 1,063 | 3,047 | 143 |
| 30 Jun 16 | 15,841 | 998 | 3,027 | 136 |
| 31 Mar 16 | 15,402 | 933 | 2,961 | 130 |
| 31 Dec 15 | 15,455 | 955 | 2,895 | 128 |
| 30 Sep 15 | 15,345 | 939 | 2,919 | 118 |
| 30 Jun 15 | 15,246 | 948 | 2,839 | 114 |
| 31 Mar 15 | 15,428 | 977 | 2,816 | 115 |
| 31 Dec 14 | 13,329 | 864 | 2,434 | 101 |
| 30 Sep 14 | 12,413 | 839 | 2,242 | 97 |
| 30 Jun 14 | 11,112 | 775 | 1,999 | 91 |
| 31 Mar 14 | 10,882 | 791 | 1,962 | 91 |
| 31 Dec 13 | 10,816 | 806 | 1,937 | 91 |
Quality Earnings: FMED has high quality earnings.
Growing Profit Margin: FMED's current net profit margins (3.4%) are higher than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FMED's earnings have declined by 20.9% per year over the past 5 years.
Accelerating Growth: FMED's earnings growth over the past year (46.5%) exceeds its 5-year average (-20.9% per year).
Earnings vs Industry: FMED earnings growth over the past year (46.5%) exceeded the Healthcare industry 15.2%.
Return on Equity
High ROE: FMED's Return on Equity (5.9%) is considered low.